D iabetes is increasing by epidemic proportions in the United States and throughout the world (1, 2) . Increased cardiovascular morbidity and mortality in patients with type 2 diabetes is well established; diabetes is associated with at least a 2-fold increased risk of coronary heart disease (CHD) and 2-to 4-fold increased risk of CHD and stroke mortality compared with patients without diabetes (3) (4) (5) . Currently two-thirds of death among persons with diabetes is related to cardiovascular disease (CVD) (5) . Furthermore, management strategies for diabetes have shifted from glucocentric to multifactorial, to identify and target patients' cardiovascular risk factors.
Formerly, diabetes was regarded as a "coronary risk equivalent," implying a 10-year cardiovascular risk of >20% for every diabetes patient (6) . This was based on an observational Finnish study by Haffner et al. (6) , which showed that people with diabetes without prior myocardial infarction (MI) had a similar risk of CHD to those with MI but without diabetes. Following the original study by Haffner et al. (6) , multiple studies from different population cohorts provided varying conclusions on the validity of the concept of coronary risk equivalency in patients with diabetes. Although some large observational studies supported the concept of coronary risk equivalency (7-10), several others did not (11) (12) (13) (14) . In a systematic review and meta-analysis, Bulugahapitiya et al. (15) 0.53 to 0.60). The results showed that patients with diabetes were at a lower risk of developing total CHD events compared with patients without diabetes with established CHD (15) . New guidelines have started to acknowledge the heterogeneity in risk and include different treatment recommendations for diabetic patients without other risk factors who are considered to be at lower risk (16, 17) . Furthermore, guidelines have suggested that further risk stratification in patients with diabetes is warranted before universal treatment (18, 19) . An important clinical question remains: do patients with asymptomatic diabetes need routine screening for CHD, and if so, how? This document reviews the evidence regarding the use of noninvasive testing to stratify asymptomatic patients with diabetes with regard to CHD risk (Central Illustration).
ROLE OF EXERCISE STRESS TESTING
Exercise testing in patients with diabetes is attractive due to low cost, simplicity, and wide availability. showed that diabetic patients with a CIMT in the fourth quartile had no significant increase in cardiovascular events (HR: 1.7, 95% CI: 0.7 to 4.3) compared with those in the first quartile.
CORONARY ARTERY CALCIUM
Histological studies have shown that the extent of coronary artery calcium (CAC) is closely associated with total coronary artery atherosclerotic plaque burden (35). Furthermore, numerous studies have conclusively proven that CAC scores predict incident CAD in the general population (36,37). Patients affected by type 2 DM harbor larger amounts of CAC than nondiabetic patients of a similar age (38); additionally the extent (39,40) and prevalence (41) of CAC in patients with type 2 diabetes asymptomatic for CAD is similar to that of patients with established CAD but without diabetes. Unlike the general population, women and men with type 2 DM have a similar extent of CAC, confirming the clinical evidence that diabetes negates the well-known advantage of women over men in prevalence and extent of atherosclerosis (39,41).
In the CACTI (Coronary Artery Calcification in Type 1 Diabetes) study (42), 656 adult type 1 DM patients showed a higher prevalence and extent of CAC than 764 age-and sex-matched control subjects with no 
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CENTRAL ILLUSTRATION Approach to Risk Assessment of Diabetic Patients
As discussed in the text several imaging modalities have been tested to risk stratify asymptomatic diabetic patients but few have provided valuable prognostic information. Diabetic women and diabetic patients with chronic kidney disease are at particularly high risk of cardiovascular
difference between sexes. Extensive vascular calcification is detectable even in young (17 to 28 years of age) adults with type 1 diabetes (43) and has been associated with factors such as genetic polymorphism for hepatic lipoxygenase (LIPC-480 T) (44), smoking, elevated serum lipoprotein(a) (32), or suboptimal glycemic control (44,45).
ASSOCIATIONS OF CAC WITH ISCHEMIA AND PRE-
DICTION OF CARDIAC EVENTS. The extent of CAC has been shown to be associated with the prevalence of inducible ischemia by single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) (46,47). In nondiabetic patients, the CAC score threshold at which the prevalence of ischemia increases substantially is >400 (46,47). In contrast, in diabetic patients this threshold has been reported to be lower (48). Several studies ( Table 1) have demonstrated that increased CAC in persons with metabolic syndrome and diabetes is associated with increased prevalence of ischemia (48), events A high proportion of adults with diabetes have a 0 or very low CAC score, which, along with the excellent prognosis of these patients, provides strong evidence that diabetes per se is not a CHD equivalent.
The study by Raggi et al. (51) was the first to document a prevalence of 39% of 0 or very low (<10) CAC in asymptomatic DM patients. In MESA (53), 38% of DM patients were reported to have a CAC score of 0, and in the HNR (Heinz Nixdorf Recall) study, 39.3% of women with diabetes and 13.4% of men with diabetes had a CAC score of 0 (50). Importantly, the absence of CAC predicted a low short-term risk of death (w1% at 5 years) for diabetic patients, which was slightly higher but statistically similar to that of nondiabetic patients.
Sequential CAC imaging has been implemented as a means to assess atherosclerosis progression. The Table 1 outlines several studies that have demonstrated that progression of CAC is a strong predictor of future MI (57, (60) (61) (62) .
In summary, CAC provides strong risk stratification of patients with diabetes, with an increase in mortality for each increase in CAC score category.
The mortality risk is higher for each CAC category in the patients with diabetes than in the patients without diabetes. However, about 40% of adult diabetic patients have a CAC score <10 and a very low mortality rate. Rapid progression of CAC identifies patients at higher risk for CHD events.
The overall evidence would support the use of CAC scanning for risk stratification and to guide management in the asymptomatic DM patient, as recommended with a Class IIa indication in the 2010 AHA/ACC guidelines (19). The prevalence of diastolic dysfunction is also greater in diabetic patients than in normal individuals and has been reported to be between 43% to 78% (69) (70) (71) therefore, care should be taken before drawing definitive conclusions based on these preliminary studies.
ECHOCARDIOGRAPHY IN PATIENTS WITH DM
GENDER DIFFERENCES IN PATIENTS WITH DM
DM is a major risk factor and predictor of adverse The presence of the metabolic syndrome also appears to increase the risk of cardiovascular events in women (116) . In the WISE (Women's Ischemia Syndrome Evaluation) study, women with angiographically significant CAD and the metabolic syndrome had significantly higher risk of cardiovascular events than those with normal metabolic status (HR: 4.93; 95% CI:
1.02 to 23.76; p < 0.05) (117) . This increased risk in women with diabetes and metabolic syndrome may be due, at least in part, to an increased prevalence of other cardiovascular risk factors such as lipid disorders, hypertension, obesity, and physical inactivity, as well as more endothelial dysfunction (118) . The metabolic syndrome and diabetes are also associated with systemic inflammation and a hypercoagulable state (117) .
Similar to nondiabetic women, diabetic women tend to present with less obstructive coronary disease compared with their male counterparts. The BARI 2D trial showed that there were no sex differences in death, MI, or cerebrovascular accident among patients enrolled in the trial (119) .
Cardiac imaging studies in women have further illustrated sex differences in diabetic patients and in those with metabolic syndrome. In an echocardiographic study by Nicolini et al. (120) , women with metabolic syndrome had higher posterior wall thickness, relative wall thickness, and concentric LV hypertrophy, and more advanced diastolic abnormalities. Such differences were not seen in men with or without metabolic syndrome (120) . Stress testing studies with cardiac imaging in symptomatic and asymptomatic diabetic women have demonstrated less extensive ischemia compared with men (80, 121) .
Despite smaller perfusion defects, the prognosis for women with DM is worse compared with men for similar summed stress scores on adenosine perfusion SPECT imaging (121) .
In summary, the risk of cardiovascular events is significantly increased in women with DM and with metabolic syndrome (122) . Similar to nondiabetic women, women with DM have a lesser burden of coronary atherosclerosis, thus leading to less ischemia on stress testing. Despite the smaller burden of disease, the symptoms and prognosis are worse than in matched male counterparts. Among individuals with end-stage renal disease, CAC is highly prevalent, progresses rapidly, and is associated with an increased risk of death (128) (129) (130) (131) (132) .
DIABETES AND CKD
CAC is due to the accumulation of calcification in the media of the vessel wall with resultant increased arterial stiffness, increased pulse wave velocity, and LV hypertrophy (133) , as well as intimal calcification, more directly related to atherosclerosis as in the general population (134) .
Analyses from the CRIC (Chronic Renal Insuffi- Go to http://www.acc.org/jaccjournals-cme to take the CME quiz for this article.
